# Fulvestrant

NDC: 63323-715
Generic name: Fulvestrant
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20190520

FDA application: NDA210326

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-715"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-715
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fabe9bd8-ac23-4df1-a89a-223d5cd38914